March 20 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED PROVIDES UPDATE ON OPERATIONS IN RESPONSE TO THE COVID-19 GLOBAL OUTBREAK
* INMED PHARMACEUTICALS - INM-088 PROGRAM REMAINS ON TRACK
* INMED PHARMACEUTICALS - ANTICIPATES BEING IN A POSITION TO SELECT APPROPRIATE DELIVERY FORMULATION FOR INM-088 IN NEAR TERM
* INMED PHARMACEUTICALS - INMED DOES NOT ANTICIPATE A SIGNIFICANT DISRUPTION IN REMAINING TREATMENTS AND COLLECTION OF DATA
* INMED PHARMACEUTICALS -DILIGENTLY PREPARING FOR SECOND HEALTHY VOLUNTEER TRIAL, STUDY 755-102-HV,AT SAME CLINICAL SITE, TO BEGIN ENROLLMENT IN MID-MAY
* INMED PHARMACEUTICALS - TO BE IN BETTER POSITION TO PROVIDE GUIDANCE ON ANY CHANGES TO DEVELOPMENT TIMELINES DURING NEXT QUARTERLY UPDATE IN MAY
* INMED PHARMACEUTICALS - DEVELOPMENT ACTIVITIES WITH CO'S BIOSYNTHESIS MANUFACTURING PLATFORM HAVE NOT SEEN ANY NEGATIVE IMPACTS DUE TO OUTBREAK